Lisa B. Pinheiro
Education
M.Fin., mathematical finance, Princeton University; Licence en sciences mathématiques, Université Libre de Bruxelles
Summary of Experience
Ms. Pinheiro has an extensive background in quantitative analysis and data science, which she has applied to various practice areas, including finance, intellectual property, biostatistics, and antitrust. In finance, she focuses on cases involving allegations of market price manipulation, misleading communications, excessive mutual fund fees, and mortgage-backed securities litigation. In particular, she has been retained by the US Department of Justice, regulatory agencies, banking institutions, and market exchanges to consult, advise, and testify on matters involving allegations of spoofing and price manipulation, as well as corresponding detection approaches. She has also applied survey analysis and statistical modeling to various intellectual property cases, including patent disputes among smartphone manufacturers, copyright tariff setting for musical works, and patent infringement in the pharmaceutical industry. She has extensive experience analyzing clinical trial, registry, and insurance claims data for both litigation and research purposes and has published manuscripts on pharmacoeconomic issues. In the antitrust field, she has acted as an expert and supported other experts in class certification and price-fixing matters involving a wide range of industries, including online search engines, computer chips, liquid-crystal display (LCD) panels, airline ticketing services, gaming, and grocery stores. Ms. Pinheiro has also authored expert reports and testified on questions relating to the modeling and calculation of royalties and damages.
Prior to joining Analysis Group, Ms. Pinheiro served as executive director of the finance group of CIRANO, where she conducted applied research projects in collaboration with private and public partners, including work on hedge funds, style analysis, credit and operational risk, and the development of integrated risk management tools for practical applications.
- Apple v. Samsung Injunction Ruling (December 2012)
- Apple v. Samsung Injunction Ruling (July 2014)
- Apple v. Samsung Trial (May 2014)
- Assessing Adverse Events
- Assessing Health Care Patent Infringement Claims
- Bone Care International v. Roxane Labs, et al.
- ContentGuard Holdings Inc. v. Google Inc.
- Quebec Coalition for Tobacco Control - Data Visualization of Smoking and Vaping
- SimpleAir v. Google, et al.
- Tribunal de commerce francophone de Bruxelles - Patrinvest v. SA Ageas
- Twitter v. Elon Musk, et al.
- United States v. Cioffi
- United States v. Mark David Radley, et al.
-
Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection
Clinical Infectious Diseases, 2024
2024Shields RK, Cheng WY, Kponee-Shovein K, Indacochea D, Gao C, Kuwer F, Joshi AV, Mitrani-Gold FS, Schwab P, Ferrinho D, Mahendran M, Pinheiro L, Royer J, Preib MT, Han J, Colgan R
-
Gender Considerations in the Analysis of Market Definition and Competitive Effects: A Practical Framework and Illustrative Example
Lexis-Nexis Antitrust Report, August 2023
2023 -
Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges
PharmacoEconomics, March 8, 2019
2019Thesmar D, Sraer D, Pinheiro L, Dadson N, Veliche R, Greenberg PE
-
Decision Making with Machine Learning in Our Modern, Data-Rich Health-Care Industry
Decision Making in a World of Comparative Effectiveness Research
2017 -
The impact of psoriasis on health care costs and patient work loss
Journal of the American Academy of Dermatology, November 2008
2008Fowler J, Duh M, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle J, Swensen A, Mallett D, Kosicki G
-
The Direct and Indirect Cost Burden of Atopic Dermatitis: An Employer-Payer Perspective
Managed Care Interface, October 2007
2007Fowler J, Duh M, Rovba L, Buteau S, Pinheiro L, Lobo F, Sung J, Doyle J, Swensen A, Mallett D, Kosicki G
-
June 3, 2021
-
September 29, 2023
-
May 22, 2024
-
April 10, 2024
-
January 12, 2024
-
December 8, 2023
-
October 10, 2023
-
September 13, 2023
-
May 10, 2023
-
April 11, 2023
-
October 29, 2021